• Facebook
  • Twitter
  • Linkedin
  • Print
Skip to content
HopeNet
  • ET Symptoms &Treatments
  • Groups/Events
  • Advisory Boards
  • Resources
  • Blog & News
  • Living with ET
  • Donate
  • About Us

New therapy enters Phase II testing

January 22, 2020 by HopeNetAdmin

Sage Therapeutics is about to begin Phase II testing of Sage-324 for Essential Tremor. There is a lot to learn about the way Sage is thinking about Neurological Disorders on their corporate website at:

  • https://www.sagerx.com/programs-research/neurologic-disorders/
  • https://www.sagerx.com/programs-research/pipeline/
  • https://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-announces-clinical-updates-and-progress-across

Share this...
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Print this page
Print
Categories Benign Essential Tremor, Essential Tremor treatment, ET research, Medical Procedures, Movement Disorders, Uncategorized
Post navigation
Is there any correlation between Essential Tremor & population density?
New Study Finds Overactive Brain Waves Cause Essential Tremor

Search HopeNET’s site:

HopeNET – Nomore Essential Tremor

14425 Coachway Drive
Centreville, VA 20120
804-754-4455
Peter Muller
Executive Director

Follow @thehopenet

Please help HopeNET by using Amazon Smile. A percentage of your Amazon purchases, 0.5%, is donated to HopeNET at no cost to you. It's easy - you must go to the list of charities that Amazon lists and click on HopeNET Inc. Centreville. Then use smile.amazon.com anytime you make your purchases.

HopeNet is a 501(c)(3) non-profit organization and welcomes your donations.

Checks can be made payable to HopeNet, Inc. and mailed to 14425 Coachway Drive, Centreville, VA 20120. Thank you for any and all contributions to HopeNet.
© 2023 HopeNet • Built with GeneratePress